Suppr超能文献

基于反应性的代谢组学揭示半胱氨酸具有类似乙二醛酶1和类似乙二醛酶2的活性。

Reactivity-based metabolomics reveal cysteine has glyoxalase 1-like and glyoxalase 2-like activities.

作者信息

Daniel Opfermann Marc, Bøgelund Søndergård Maria, Vase Bech Louise, Nielsen Camilla B, Mahía Alejandro, Brinck Holt Charlotte, Wang Tingting, Bisgaard Olesen Sarah, Frisch Kim, Appel Østergaard Jakob, Britz Dieter, Lykke Nielsen Kirstine, Galligan James J, Poulsen Thomas B, Hansen Jakob, Johannsen Mogens

机构信息

Department of Forensic Medicine, Aarhus University, Aarhus, Denmark.

Department of Chemistry, Aarhus University, Aarhus, Denmark.

出版信息

Nat Chem Biol. 2025 May 28. doi: 10.1038/s41589-025-01909-0.

Abstract

Methylglyoxal (MG) is a reactive metabolite involved in diabetes and aging through the formation of protein adducts. Less is known about the extent that MG and its metabolic product S-D-lactoylglutathione (LGSH) form adducts with cell metabolites. Using a 'symmetric' isotope-labeled and reactivity-based metabolomics approach in living cells, we found over 200 adducts and, surprisingly, discovered that 10 of the most abundant are lactoylated amino acids mainly derived from LGSH. The most abundant adduct D-Lac-Cys is formed rapidly between LGSH and cysteine, whereas the diastereoisomer L-Lac-Cys is formed directly from MG and cysteine, assigning cysteine with both glyoxalase 1-like and glyoxalase 2-like activity. Cellular cysteine and MG dynamically regulate D-Lac-Cys and L-Lac-Cys levels and the adducts are increased in diabetes, suggesting their use as novel biomarkers. Lastly, cysteine amides, as proxies for protein cysteines, also undergo lactoylation by MG and LGSH, suggesting the existence of two additional pathways for nonenzymatic lactoylation of proteins.

摘要

甲基乙二醛(MG)是一种活性代谢产物,可通过形成蛋白质加合物参与糖尿病和衰老过程。关于MG及其代谢产物S-D-乳酰谷胱甘肽(LGSH)与细胞代谢物形成加合物的程度,人们了解较少。我们在活细胞中使用一种“对称”的同位素标记且基于反应性的代谢组学方法,发现了200多种加合物,令人惊讶的是,还发现最丰富的10种加合物是主要源自LGSH的乳酰化氨基酸。最丰富的加合物D-乳酰半胱氨酸是由LGSH和半胱氨酸迅速形成的,而非对映异构体L-乳酰半胱氨酸则直接由MG和半胱氨酸形成,这赋予了半胱氨酸类似乙二醛酶1和乙二醛酶2的活性。细胞内的半胱氨酸和MG动态调节D-乳酰半胱氨酸和L-乳酰半胱氨酸的水平,且这些加合物在糖尿病中会增加,这表明它们可用作新型生物标志物。最后,半胱氨酸酰胺作为蛋白质半胱氨酸的替代物,也会被MG和LGSH乳酰化,这表明存在另外两条蛋白质非酶促乳酰化的途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验